Mannose phosphorylation in health and disease

作者：Kollmann Katrin; Pohl Sandra; Marschner Katrin; Encarnacao Marisa; Sakwa Imme; Tiede Stephan; Poorthuis Ben J; Luebke Torben; Mueller Loennies Sven; Storch Stephan; Braulke Thomas^*

来源：European Journal of Cell Biology, 2010, 89(1): 117-123.

DOI：10.1016/j.ejcb.2009.10.008

• Mucolipidosis
• GNPTG
• GNPTAB
• Mannose 6-phosphate
• Lysosomal enzymes
• Lysosomal trafficking disorder
• GlcNAc-1-phosphotransferase
• Knock-in mouse model

Lysosomal hydrolases catalyze the degradation of a variety of macromolecules including proteins, carbohydrates, nucleic acids and lipids. The biogenesis of lysosomes or lysosome-related organelles requires a continuous substitution of soluble acid hydrolases and lysosomal membrane proteins. The targeting of lysosomal hydrolases depends on mannose 6-phosphate residues (M6P) that are recognized by specific receptors mediating their transport to an endosomal/prelysosomal compartment. The key role in the formation of M6P residues plays the GlcNAc-1-phosphotransferase localized in the Golgi apparatus. Two genes have been identified recently encoding the type III alpha/beta-subunit precursor membrane protein and the soluble gamma-subunit of GlcNAc-1-phosphotransferase. Mutations in these genes result in two severe diseases, mucolipidosis type II (MLII) and III (MLIII), biochemically characterized by the missorting of multiple lysosomal hydrolases due to impaired formation of the M6P recognition marker, and general lysosomal dysfunction. This review gives an update on structural properties, localization and functions of the GlcNAc-1-phosphotransferase subunits and improvements of pre- and postnatal diagnosis of ML patients. Further, the generation of recombinant single-chain antibody fragments against M6P residues and of new mouse models of MLII and MLIII will have considerable impact to provide deeper insight into the cell biology of lysosomal dysfunctions and the pathomechanisms underlying these lysosomal disorders.

• 出版日期2010-1